Search Results for “IF”

Skip to content Skip to sidebar Skip to footer

Membership Login

Launch of EAHAD Unified Coagulation Factor Variant Databases

GenericAugust 2, 20242KViews 0Likes 0Comments

Launch of EAHAD Unified Coagulation Factor Variant Databases We are pleased to report that the existing EAHAD individual coagulation factor variant web databases have been brought together into a single unified site at https://dbs.eahad.org. This move harmonizes all existing EAHAD databases and takes advantage of improvements in web hosting and security. The unified site collects…

The first EAHAD Podcast is available now on Spotify!

E-Learning, EAHAD Academy, PodcastApril 11, 2023796Views 0Likes 0Comments

Looking for an informative and engaging podcast on bleeding disorders? Look no further than the EAHAD Podcast, now available on Spotify Podcasts! Hosted by experts in the field, the EAHAD Podcast is your go-to source for the latest news, research, and information on bleeding disorders. Our very first episode features the E-learning Working Group and focuses…

Haemophilia Centre Certification & Audit Working Group formed

Gene TherapyMarch 30, 20211KViews 0Likes 0Comments

With the new changing landscape of haemophilia treatment in Europe, EAHAD, in partnership with the European Haemophilia Consortium, decided not only to continue with the certification project first started in 2013 but also to review and update it in order to reflect the specialised services required to monitor patients who may receive new treatments.

Nurses Committee Newsletter – Spring 2026

April 17, 20261KViews 0Likes 0Comments

Page (post) title HomePage (post) title EAHAD 2026 The nurses’ stream at EAHAD 2026 in Dublin was attended by a highly engaged audience and inspirational speakers. Throughout the day, we explored key concepts of care for people affected by bleeding disorders. Here is a summary of the main highlights and takeaways from the day. Joint Session…

Clinical Implications of Roctavian’s Market Withdrawal

2026, EAHAD Events, EventsApril 7 @ 5:30 pm - 6:30 pm743Views 0Likes 0Comments

The recent withdrawal of Roctavian from the market has raised important questions for clinicians, patients, and healthcare systems involved in the management of haemophilia A gene therapy. As the first approved GT medicine for adults with severe haemophilia A, Roctavian represented a significant milestone in the evolution of treatment options, and the effects of its…

Webinar: Clinical Implications of Roctavian’s Market Withdrawal

Gene TherapyMarch 17, 20263KViews 0Likes 0Comments

The recent withdrawal of Roctavian from the market has raised important questions for clinicians, patients, and healthcare systems involved in the management of haemophilia A. As the first approved gene therapy for adults with severe haemophilia A, Roctavian represented a significant milestone in the evolution of treatment options. This webinar will explore the clinical implications…

Leading the Future of EAHAD: Ana Boban, EAHAD President 2026-2028

Executive CommitteeMarch 3, 20263KViews 0Likes 0Comments

An Interview with Ana Boban With a clear vision grounded in continuity, innovation and collaboration, Ana Boban, the new EAHAD President, outlined her priorities for the years ahead during the Annual General Meeting held on Tuesday, 4th February 2026 in Dublin, on the occasion of the EAHAD 2026 Congress. Ana, what are the main pillars of…

Call for Applications: EAHAD Psychosocial Professionals Committee

Psycosocial Professionals, VacanciesFebruary 24, 20263KViews 0Likes 0Comments

EAHAD is inviting a psychologist or social worker active in the haemophilia and bleeding disorders field to apply for up to two vacant posts on its Psychosocial Professionals Committee. The position is for a three-year term that would begin in May 2026. If you are interested in applying, please send a short letter of motivation…

EAHAD 2026 Congress Press Release

CongressFebruary 23, 20261KViews 0Likes 0Comments

Brussels, Belgium, 25 February 2026 - The European Association for Haemophilia and Allied Disorders (EAHAD) is delighted to announce the successful conclusion of its 2026 Congress, which took place in Dublin, Ireland, from 3 to 6 February. Bringing together more than 2,000 delegates from over 77 countries, the Congress served as a vibrant forum for…

Interest for the EAHAD 2027 WGBD WG Workshop

January 30, 20261KViews 0Likes 0Comments

Page (post) title HomePage (post) title Sign up for Psychosocial Professionals Network EAHAD will use the information you provide in this form to be in touch with you and to provide updates on psychosocial care-related activities. Please let us know all the ways you would like to hear from us. Email from the EAHAD Psychosocial Professionals Committee…

Launch of EAHAD Unified Coagulation Factor Variant Databases

The first EAHAD Podcast is available now on Spotify!

Haemophilia Centre Certification & Audit Working Group formed

Nurses Committee Newsletter – Spring 2026

Clinical Implications of Roctavian’s Market Withdrawal

Webinar: Clinical Implications of Roctavian’s Market Withdrawal

Leading the Future of EAHAD: Ana Boban, EAHAD President 2026-2028

Call for Applications: EAHAD Psychosocial Professionals Committee

EAHAD 2026 Congress Press Release

Interest for the EAHAD 2027 WGBD WG Workshop

Knowledge. Collaboration. Impact.

European Association for Haemophilia and Allied Disorders

Email

Latest news

Follow us